Loading clinical trials...
Loading clinical trials...
This trial is conducted in Europe. The aim of this trial is to assess and compare the efficacy and safety of two dose levels of somatropin over a long period (till final height is reached). This trial...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Novo Nordisk A/S
NCT06723392 · Preterm Birth, Small for Gestational Age (SGA), and more
NCT06957769 · Low Birth Weight Baby, Small for Gestational Age (SGA), and more
NCT06918236 · Fetal Growth Restriction (FGR), Preeclampsia, and more
NCT04720690 · Arterial Stiffness, Fetal Growth Retardation, and more
NCT01604395 · Growth Hormone Deficiency, Turner Syndrome, and more
Novo Nordisk Investigational Site
Rotterdam
Novo Nordisk Investigational Site
Rotterdam
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions